Invenra Built an Antibody Factory. Then One of Its Molecules Reached Humans.

The Madison biotech spent years making two-target antibodies easier to build, screen and manufacture. Now a partner-discovered molecule is in a Phase 1 trial - and the operating lesson may be more reusable than the science.